help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adachi, T.
Right arrow Articles by Makino, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adachi, T.
Right arrow Articles by Makino, S.

Am. J. Respir. Crit. Care Med., Vol 151, No. 3, 03 1995, 618-623.

Eosinophil viability-enhancing activity in sputum from patients with bronchial asthma, Contributions of interleukin-5 and granulocyte/macrophage colony-stimulating factor

T Adachi, S Motojima, A Hirata, T Fukuda and S Makino
Department of Respiratory Medicine, Kihara Hospital, Tokyo, Japan.

To investigate the mechanisms of eosinophil activation in the airways of patients with asthma, we attempted to detect eosinophil-activating cytokines in sputum extracts obtained from asthmatic patients during acute attacks or in remission by eosinophil survival assay. Purified guinea pig eosinophils were cultured in the presence or absence of sputum extracts, and the eosinophil viability was measured on Day 4. Eosinophil viability in the presence of sputum extracts derived from patients during moderate or severe attacks was significantly higher than that for sputum obtained from patients in remission or during mild attacks or from those with other respiratory diseases, including bronchiectasis and diffuse panbronchiolitis (p < 0.05). The total symptom score during the week prior to sputum collection correlated with the eosinophil viability (rs = 0.79, p < 0.01). Eosinophil viability-enhancing activity (EVEA) in the sputum of asthmatic patients with moderate or severe attacks was neutralized by anti-IL-5 antibody and by anti-GM-CSF antibody by 19.9 +/- 13.7% and 76.9 +/- 8.2% (mean +/- SEM, n = 7), respectively. EVEA was completely neutralized by a combination of anti-IL-5 and anti-GM-CSF antibodies. There was a significant correlation between the concentration of eosinophil cationic protein (ECP) in sputum extracts and the eosinophil viability (rs = 0.54, p < 0.05). These findings suggest that IL-5 and GM-CSF are present in the sputum during asthma attacks and that these cytokines are at least partially responsible for eosinophil activation in asthma.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
P. Rytila, M. Plataki, F. Bucchieri, M. Uddin, G. Nong, V. L. Kinnula, and R. Djukanovic
Airway neutrophilia in COPD is not associated with increased neutrophil survival
Eur. Respir. J., December 1, 2006; 28(6): 1163 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
Z ALLAKHVERDI, M ALLAM, A GUIMOND, N FERRARI, K ZEMZOUMI, R SEGUIN, L PAQUET, and P. M RENZI
Multitargeted Approach Using Antisense Oligonucleotides for the Treatment of Asthma
Ann. N.Y. Acad. Sci., October 1, 2006; 1082(1): 62 - 73.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. A. Pouladi, C. S. Robbins, F. K. Swirski, M. Cundall, A. N.J. McKenzie, M. Jordana, S. D. Shapiro, and M. R. Stampfli
Interleukin-13-Dependent Expression of Matrix Metalloproteinase-12 Is Required for the Development of Airway Eosinophilia in Mice
Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 84 - 90.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C.J.A. Duncan, A. Lawrie, M.G. Blaylock, J.G. Douglas, and G.M. Walsh
Reduced eosinophil apoptosis in induced sputum correlates with asthma severity
Eur. Respir. J., September 1, 2003; 22(3): 484 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. G. Zangrilli
Regulation of Eosinophil Viability by Cytokines
Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 388 - 390.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
M. T. Borchers, P. J. Justice, T. Ansay, V. Mancino, M. P. McGarry, J. Crosby, M. I. Simon, N. A. Lee, and J. J. Lee
Gq Signaling Is Required for Allergen-Induced Pulmonary Eosinophilia
J. Immunol., April 1, 2002; 168(7): 3543 - 3549.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A.-S. Jang, I.-S Choi, S. Lee, J.-P. Seo, S.-W. Yang, and C.-S. Park
Bcl-2 expression in sputum eosinophils in patients with acute asthma
Thorax, May 1, 2000; 55(5): 370 - 374.
[Abstract] [Full Text]

Home page
 IOVSHome page
A. Solomon, R. Shmilowich, D. Shasha, J. Frucht–Pery, J. Pe’er, S. Bonini, and F. Levi–Schaffer
Conjunctival Fibroblasts Enhance the Survival and Functional Activity of Peripheral Blood Eosinophils In Vitro
Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1038 - 1044.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Arima, J. Plitt, C. Stellato, C. Bickel, S. Motojima, S. Makino, T. Fukuda, and R. P. Schleimer
Expression of Interleukin-16 by Human Epithelial Cells . Inhibition by Dexamethasone
Am. J. Respir. Cell Mol. Biol., December 1, 1999; 21(6): 684 - 692.
[Abstract] [Full Text]

Home page
 FASEB J.Home page
F. Spinozzi, E. Agea, M. Fizzotti, G. Bassotti, A. Russano, S. Droetto, O. Bistoni, F. Grignani, and A. Bertotto
Role of T-helper type 2 cytokines in down-modulation of Fas mRNA and receptor on the surface of activated CD4+ T cells: molecular basis for the persistence of the allergic immune response
FASEB J, December 1, 1998; 12(15): 1747 - 1753.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society